Filing Details
- Accession Number:
- 0001209191-19-048913
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-09 16:52:41
- Reporting Period:
- 2019-09-06
- Accepted Time:
- 2019-09-09 16:52:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1262104 | Mei Pharma Inc. | MEIP | Pharmaceutical Preparations (2834) | 510407811 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1371859 | Anna Christine White | C/O Mei Pharma, Inc. 3611 Valley Centre Drive, Suite 500 San Diego CA 92130 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-09-06 | 15,000 | $1.74 | 15,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The shares purchased by the reporting person are held through an Individual Retirement Account.
- The weighted average purchase price for the transaction reported was $1.7383, and the range of prices was between $1.725 and $1.74. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.